chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: developed a sore throat with like a limp feeling in it; sore arm; Diarrhea; chills; achy body; nauseas; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (developed a sore throat with like a limp feeling in it), PAIN IN EXTREMITY (sore arm), DIARRHOEA (Diarrhea), CHILLS (chills) and MYALGIA (achy body) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (developed a sore throat with like a limp feeling in it), PAIN IN EXTREMITY (sore arm), DIARRHOEA (Diarrhea), CHILLS (chills), MYALGIA (achy body) and NAUSEA (nauseas). At the time of the report, OROPHARYNGEAL PAIN (developed a sore throat with like a limp feeling in it), PAIN IN EXTREMITY (sore arm), DIARRHOEA (Diarrhea), CHILLS (chills), MYALGIA (achy body) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: developed a sore throat with like a limp feeling in it; sore arm; Diarrhea; chills; achy body; nauseas; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (developed a sore throat with like a limp feeling in it), PAIN IN EXTREMITY (sore arm), DIARRHOEA (Diarrhea), CHILLS (chills) and MYALGIA (achy body) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (developed a sore throat with like a limp feeling in it), PAIN IN EXTREMITY (sore arm), DIARRHOEA (Diarrhea), CHILLS (chills), MYALGIA (achy body) and NAUSEA (nauseas). At the time of the report, OROPHARYNGEAL PAIN (developed a sore throat with like a limp feeling in it), PAIN IN EXTREMITY (sore arm), DIARRHOEA (Diarrhea), CHILLS (chills), MYALGIA (achy body) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 12-Mar-2021, PAIN IN EXTREMITY (soreness in arm) had resolved.            Concomitant medication use was not reported.   Treatment information was not reported.   This case was linked to MOD-2021-202143 (Patient Link).   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTIs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTIs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (UTIs). At the time of the report, URINARY TRACT INFECTION (UTIs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.    Reporter did not allow further contact
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Myalgia, Pain in extremity
Clinical narrative: Flu like symptoms; leg ached; Chills; Headache; arm ached; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (leg ached), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (arm ached) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.     On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (leg ached), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (arm ached). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 08-Apr-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (leg ached), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, MYALGIA (arm ached) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.    This case was linked to MOD-2021-202042 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: This spontaneous case reported by an other healthcare professional, describes the occurrence of malaise (felt sick) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced malaise (felt sick). At the time of the report, malaise (felt sick) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments. No concomitant medication or treatment information reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Diarrhea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and VOMITING (Vomiting) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and VOMITING (Vomiting). At the time of the report, DIARRHOEA (Diarrhea) and VOMITING (Vomiting) outcome was unknown.            Concomitant medication included Diabetes medications.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Platelet count, Platelet count abnormal
Clinical narrative: Platelet count is up to 97. Yes it has been lower before that not as low as the 92 except for when I was on blood thinners in the hospital in 2019; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT ABNORMAL (Platelet count is up to 97. Yes it has been lower before that not as low as the 92 except for when I was on blood thinners in the hospital in 2019) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PLATELET COUNT ABNORMAL (Platelet count is up to 97. Yes it has been lower before that not as low as the 92 except for when I was on blood thinners in the hospital in 2019). At the time of the report, PLATELET COUNT ABNORMAL (Platelet count is up to 97. Yes it has been lower before that not as low as the 92 except for when I was on blood thinners in the hospital in 2019) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2019, Platelet count: inconclusive (Inconclusive) been lower before that not as low as the 92 except for when the patient was on blood thinners in the hospital in 2019.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication are reported.  Treatment information is not reported
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: heart has been racing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PALPITATIONS (heart has been racing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PALPITATIONS (heart has been racing). At the time of the report, PALPITATIONS (heart has been racing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Stent placement
Clinical narrative: Stent insertion NOS; This spontaneous case was reported by a patient family member or friend and describes the occurrence of STENT PLACEMENT (Stent insertion NOS) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced STENT PLACEMENT (Stent insertion NOS). At the time of the report, STENT PLACEMENT (Stent insertion NOS) outcome was unknown. Not Provided          No Concomitant  and Treatment medications was reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm was sore) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Down's syndrome.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Arm was sore). At the time of the report, MYALGIA (Arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications included Thyroid medication for hypothyroidism.  Treatment information included ice.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fevers; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Jun-2021 and was forwarded to Moderna on 03-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fevers) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fevers) and CHILLS (Chills). At the time of the report, PYREXIA (Fevers) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I had side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I had side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I had side effects). At the time of the report, VACCINATION COMPLICATION (I had side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in my left upper arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (pain in my left upper arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in my left upper arm). At the time of the report, PAIN IN EXTREMITY (pain in my left upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Fatigue, Headache, Left ventricular hypertrophy
Clinical narrative: headache has consistently increased recently to a 4/10 than previously; Fatigue; Left ventricular hypertrophy; This spontaneous case was reported by a pharmacist and describes the occurrence of LEFT VENTRICULAR HYPERTROPHY (Left ventricular hypertrophy), FATIGUE (Fatigue) and HEADACHE (headache has consistently increased recently to a 4/10 than previously) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product AGALSIDASE BETA (FABRAZYME) powder for concentrate for solution for injection/infusion for Fabry's disease.    No medical history reported.  Concomitant products included MACROGOL 3350 (MIRALAX), NORMAL SALINE, WATER FOR INJECTION (STERILE WATER FOR INJ.), CALCIUM, TADALAFIL (CIALIS), MULTIVITAMIN [VITAMINS NOS], LOSARTAN, METOPROLOL, SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM), FINASTERIDE and AMITRIPTYLINE for Adverse event.   On 02-Feb-2017, the patient started AGALSIDASE BETA (FABRAZYME) (Intravenous) 80. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced LEFT VENTRICULAR HYPERTROPHY (Left ventricular hypertrophy). On 20-Apr-2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced HEADACHE (headache has consistently increased recently to a 4/10 than previously). At the time of the report, LEFT VENTRICULAR HYPERTROPHY (Left ventricular hypertrophy), FATIGUE (Fatigue) and HEADACHE (headache has consistently increased recently to a 4/10 than previously) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Echocardiogram: left ventricle hypertrophy (Inconclusive) Left ventricle hypertrophy.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up received on 08-JUN-2021 contains NNI.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Cyst, Erythema, Fatigue, Feeling abnormal, Nausea
Clinical narrative: little bump/big, thick plaque-kind pieces on her skin; redness; nausea; so fatigued; felt horrible, could not get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt horrible, could not get out of bed), CYST (little bump/big, thick plaque-kind pieces on her skin), ERYTHEMA (redness), NAUSEA (nausea) and FATIGUE (so fatigued) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 001BZIA) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced FEELING ABNORMAL (felt horrible, could not get out of bed), NAUSEA (nausea) and FATIGUE (so fatigued). On 15-Apr-2021, the patient experienced CYST (little bump/big, thick plaque-kind pieces on her skin) and ERYTHEMA (redness). At the time of the report, FEELING ABNORMAL (felt horrible, could not get out of bed), CYST (little bump/big, thick plaque-kind pieces on her skin), ERYTHEMA (redness), NAUSEA (nausea) and FATIGUE (so fatigued) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.  Patient did not have any side effects after the first dose.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Had shingles after Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Had shingles after Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Had shingles after Moderna vaccine). At the time of the report, HERPES ZOSTER (Had shingles after Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were reported.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Pyrexia
Clinical narrative: Dizziness; Nausea; Headache; Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jun-2021 and was forwarded to Moderna on 02-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, the patient experienced DIZZINESS (Dizziness). 01-Jun-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, DIZZINESS (Dizziness), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Subcutaneous abscess
Clinical narrative: 6 abscesses; This spontaneous case was reported by a consumer and describes the occurrence of SUBCUTANEOUS ABSCESS (6 abscesses) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV disease. Concomitant products included COBICISTAT, DARUNAVIR ETHANOLATE, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (SYMTUZA) for HIV infection.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SUBCUTANEOUS ABSCESS (6 abscesses). The patient was treated with Surgery for Subcutaneous abscess. At the time of the report, SUBCUTANEOUS ABSCESS (6 abscesses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was prescribed Septra initially and later the drug was replaced with Enaumentin. Patient also reported to be on 40 days antibiotic drug (unspecified).   This case was linked to MOD-2021-203334 (Patient Link).
Sex: F
Vaccine: COVID19, UNK
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: 102.7 degree fever; Chills; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (102.7 degree fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product BOSENTAN for Pulmonary hypertension.    Concurrent medical conditions included Pulmonary hypertension. Concomitant products included SILDENAFIL CITRATE for an unknown indication.   On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started BOSENTAN (unknown route) 125 milligram twice a day. On 07-May-2021, the patient experienced PYREXIA (102.7 degree fever), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PYREXIA (102.7 degree fever), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea exertional, Mobility decreased
Clinical narrative: This spontaneous case was reported by an other and describes the occurrence of DYSPNOEA EXERTIONAL (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot), MOBILITY DECREASED (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot) and ASTHENIA (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA EXERTIONAL (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot), MOBILITY DECREASED (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot) and ASTHENIA (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot). At the time of the report, DYSPNOEA EXERTIONAL (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot), MOBILITY DECREASED (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot) and ASTHENIA (trouble breathing, weakness, walking up a set of stairs etc after the 1st shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Gait inability
Clinical narrative: Back Pain; Cannot walk; hurt him to the point where it felt like a shock was sent from the back to lower ankles; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jun-2021 and was forwarded to Moderna on 02-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back Pain), GAIT INABILITY (Cannot walk) and ARTHRALGIA (hurt him to the point where it felt like a shock was sent from the back to lower ankles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back Pain), GAIT INABILITY (Cannot walk) and ARTHRALGIA (hurt him to the point where it felt like a shock was sent from the back to lower ankles). At the time of the report, BACK PAIN (Back Pain), GAIT INABILITY (Cannot walk) and ARTHRALGIA (hurt him to the point where it felt like a shock was sent from the back to lower ankles) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received first dose and in one week patient experienced back pain, cannot walk and stated it hurt him to the point where it felt like a shock was sent from the back to lower ankles ( like sciatic nerve) and patient thought is it Guillain barre syndrome?. The patient stated that he wanted to see the doctor in person, but the doctor could only see him over a video call. The patient shortly thereafter refused to provide additional details about an adverse event.  No concomitant medication was reported.  No treatment medication was reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Subcutaneous abscess
Clinical narrative: Abscesses of skin; This spontaneous case was reported by a consumer and describes the occurrence of SUBCUTANEOUS ABSCESS (Abscesses of skin) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 026B21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (After receiving 1st dose of vaccine, 6 Abscesses were appeared, One on lower back and other on right tight and). Concurrent medical conditions included HIV disease (Not Detectable). Concomitant products included COBICISTAT, DARUNAVIR ETHANOLATE, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (SYMTUZA) for HIV disease.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SUBCUTANEOUS ABSCESS (Abscesses of skin). The patient was treated with AMOXICILLIN, CLAVULANIC ACID (AUGMENTINE [AMOXICILLIN;CLAVULANIC ACID]) at an unspecified dose and frequency and Surgery (third one on left arm, right under the wrist, after second dose of vaccine) for Subcutaneous abscess. At the time of the report, SUBCUTANEOUS ABSCESS (Abscesses of skin) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-203102 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lethargy, Pain in extremity
Clinical narrative: slight sore arm; Lethargic; Headache; some tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slight sore arm), FATIGUE (some tiredness), LETHARGY (Lethargic) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced FATIGUE (some tiredness). On 17-Feb-2021, the patient experienced LETHARGY (Lethargic) and HEADACHE (Headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (slight sore arm). At the time of the report, PAIN IN EXTREMITY (slight sore arm), FATIGUE (some tiredness), LETHARGY (Lethargic) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned that he was taking Lopressor and cholesterol medicine as concomitant medications. Treatment information was not provided.    This case was linked to MOD-2021-030281, MOD-2021-030281 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Illness, Myalgia, Pain
Clinical narrative: some pain and soreness, sick for a couple hours then it was gone by morning; some pain and soreness, sick for a couple hours then it was gone by morning; some pain and soreness, sick for a couple hours then it was gone by morning; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (some pain and soreness, sick for a couple hours then it was gone by morning), ILLNESS (some pain and soreness, sick for a couple hours then it was gone by morning) and MYALGIA (some pain and soreness, sick for a couple hours then it was gone by morning) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (some pain and soreness, sick for a couple hours then it was gone by morning), ILLNESS (some pain and soreness, sick for a couple hours then it was gone by morning) and MYALGIA (some pain and soreness, sick for a couple hours then it was gone by morning). At the time of the report, PAIN (some pain and soreness, sick for a couple hours then it was gone by morning), ILLNESS (some pain and soreness, sick for a couple hours then it was gone by morning) and MYALGIA (some pain and soreness, sick for a couple hours then it was gone by morning) had resolved.      Treatment of these events were not provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Injection site pain, Mobility decreased
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (brain fog), decreased mobility (slightly limited arm mobility), dizziness, injection site pain (arm pain at site of injection) and fatigue in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 036B21A and 021B21A) for COVID-19 immunization. No medical history reported. On Apr 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 13, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 13, 2021, patient experienced feeling abnormal (brain fog), decreased mobility (slightly limited arm mobility), dizziness, injection site pain (arm pain at site of injection) and fatigue. On May 15, 2021, dizziness and fatigue resolved. At the time of the report, feeling abnormal (brain fog), decreased mobility (slightly limited arm mobility) and injection site pain (arm pain at site of injection) resolved. Reporter did not allow further contact.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fell so tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (Fell so tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fell so tired). At the time of the report, FATIGUE (Fell so tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided.   Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pain in extremity
Clinical narrative: Soreness of arm; Pain; Flu types symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm), PAIN (Pain) and INFLUENZA LIKE ILLNESS (Flu types symptoms) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm), PAIN (Pain) and INFLUENZA LIKE ILLNESS (Flu types symptoms). At the time of the report, PAIN IN EXTREMITY (Soreness of arm), PAIN (Pain) and INFLUENZA LIKE ILLNESS (Flu types symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment medications were not given.   This case was linked to MOD-2021-040914 (Patient Link).
Sex: M
Vaccine: COVID19, UNK
Symptoms: Adverse drug reaction, Fatigue, Pain
Clinical narrative: Generalized aching; Drug side effect; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Generalized aching), ADVERSE DRUG REACTION (Drug side effect) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No medical history was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN (Generalized aching), ADVERSE DRUG REACTION (Drug side effect) and FATIGUE (Fatigue). At the time of the report, PAIN (Generalized aching) and FATIGUE (Fatigue) had resolved and ADVERSE DRUG REACTION (Drug side effect) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN (Generalized aching) and FATIGUE (Fatigue) to be probably related. No further causality assessment was provided for ADVERSE DRUG REACTION (Drug side effect).    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: chills; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), HEADACHE (headache) and PYREXIA (fever). At the time of the report, CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.            Concomitant medications were not reported.  No treatment details were provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Injection site pain
Clinical narrative: Tenderness at injection site; some bruising in hands; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (some bruising in hands) and INJECTION SITE PAIN (Tenderness at injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     THERE IS NO MEDICAL HISTORY PROVIDED BY THE REPORTER.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced CONTUSION (some bruising in hands). On an unknown date, the patient experienced INJECTION SITE PAIN (Tenderness at injection site). At the time of the report, CONTUSION (some bruising in hands) and INJECTION SITE PAIN (Tenderness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant drugs includes thyroid medication,blood pressure medication, cholestreol medication. no treatment drugs included   This case was linked to MOD-2021-039961, MOD-2021-039961 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: arm  was really sore; ache in the whole body; shivering; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm  was really sore), MYALGIA (ache in the whole body), CHILLS (shivering) and PYREXIA (fever) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm  was really sore), MYALGIA (ache in the whole body), CHILLS (shivering) and PYREXIA (fever). On 21-Jan-2021, MYALGIA (ache in the whole body) had resolved. On 22-Jan-2021, PAIN IN EXTREMITY (arm  was really sore), CHILLS (shivering) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Body temperature: 101 degree fahrenheit (High) 101 degree Fahrenheit.         No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-022349 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Aug-2021: Follow-up information received contains non-significant information. On 16-Aug-2021: Follow-up information received contains no new Information.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and FATIGUE (fatigue). At the time of the report, PYREXIA (Fever) and FATIGUE (fatigue) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   This case was linked to MOD-2021-004679 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: two episodes of vertigo; Lightheadedness and dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (two episodes of vertigo) and DIZZINESS (Lightheadedness and dizziness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 030L20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included QUINAPRIL, CELECOXIB (CELEBREX) and AMLODIPINE BESILATE (NORVASC) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (two episodes of vertigo) and DIZZINESS (Lightheadedness and dizziness). At the time of the report, VERTIGO (two episodes of vertigo) outcome was unknown and DIZZINESS (Lightheadedness and dizziness) had not resolved.            .  No concomitant medication was provided by the reporter.   No treatment information was provided by the reporter.   This case was linked to MOD-2021-018255 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received on 03-jun-2021 contains information about 2nd dose
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered
Clinical narrative: 3 patients dosed from the first vial before particle discovery; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (3 patients dosed from the first vial before particle discovery) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (3 patients dosed from the first vial before particle discovery). On 22-May-2021, POOR QUALITY PRODUCT ADMINISTERED (3 patients dosed from the first vial before particle discovery) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  3 patients dosed from the first vial before particle discovery. The particle looks clear with black spots on it and about 1 millimeter in size. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (5 patients dosed with particle in vials) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history provided by the reporter. On 22-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (5 patients dosed with particle in vials). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (5 patients dosed with particle in vials) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD-2021-206071.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: very tired; very bad headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (very tired) and HEADACHE (very bad headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (very tired) and HEADACHE (very bad headache). At the time of the report, FATIGUE (very tired) and HEADACHE (very bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter reported that the events were for 2 days.  No concomitant medications were reported  No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (bad headache). At the time of the report, HEADACHE (bad headache) outcome was unknown.            No concomitant medications reported. No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (would fall down when I walk), FATIGUE (Very tired) and VOMITING (Threw up twice) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 027C21A) for COVID-19 vaccination.  No Medical History information was reported. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced GAIT DISTURBANCE (would fall down when I walk). 02-Jun-2021, the patient experienced FATIGUE (Very tired) and VOMITING (Threw up twice). At the time of the report, GAIT DISTURBANCE (would fall down when I walk), FATIGUE (Very tired) and VOMITING (Threw up twice) outcome was unknown. Patient stated she did not experience these side effects after the 1st dose. The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable. Concomitant medications were not provided. Treatment information was not provided.